[Overseas Drug Safety Information 2008. Risk of infectious diseases associated with the use of immunosuppressive drugs].
Amanuma
Kimiko
K
Food and Drug Administration.
Morikawa
Kaoru
K
D016907:Adverse Drug Reaction Reporting Systems; D000911:Antibodies, Monoclonal / Q000008:administration & dosage / Q000009:adverse effects*; D003141:Communicable Diseases / Q000209:etiology*; D004346:Drug Information Services; D064420:Drug-Related Side Effects and Adverse Reactions; D006801:Humans; D007166:Immunosuppressive Agents / Q000008:administration & dosage / Q000009:adverse effects*; D007577:JC Virus / Q000472:pathogenicity; D007968:Leukoencephalopathy, Progressive Multifocal / Q000209:etiology*; D012306:Risk; D018570:Risk Assessment; D014409:Tumor Necrosis Factor-alpha / Q000037:antagonists & inhibitors
D000911:Antibodies, Monoclonal; D007166:Immunosuppressive Agents; D014409:Tumor Necrosis Factor-alpha